Loading organizations...
Loading organizations...
Biopharmaceutical company developing drugs for CNS disorders.
Myosin Therapeutics has raised $5.0M across 2 funding rounds.
Myosin Therapeutics has raised $5.0M in total across 2 funding rounds.
Myosin Therapeutics has raised $5.0M in total across 2 funding rounds.
Myosin Therapeutics's investors include Florida Department of Health, Dave Adams, DeepWork Capital, Florida Opportunity Fund, Dynagrow Capital, Mayo Clinic, Sontag Foundation.
Myosin Therapeutics has raised $5.0M across 2 funding rounds. Most recently, it raised $2.0M Grant - 2026-03 in March 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2026 | $2.0M Grant - 2026-03 | Florida Department of Health | |
| Mar 3, 2025 | $3.0M Seed | Dave Adams, DeepWork Capital, Florida Opportunity Fund, Dave Adams | Dynagrow Capital, Mayo Clinic, Sontag Foundation |